DELCATH SYSTEMS, INC. — Director's Dealing 2022

May 17, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DELCATH SYSTEMS, INC. (DCTH)
CIK: 0000872912
Period of Report: 2022-05-04

Reporting Person: Muir Kevin (See Remarks)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$15.32	2030-12-07	Common Stock (30000)		Direct
Stock Option (Right to Buy)	$10.16	2031-08-05	Common Stock (40000)		Direct
Stock Option (Right to Buy)	$7.14	2032-02-08	Common Stock (38499)		Direct

Footnotes

F1: The option vests and becomes exercisable as follows: 10,000 shares on December 1, 2021, and the remaining 20,000 shares vest and become exercisable in 24 equal monthly installments starting on January 1, 2022 and monthly thereafter, for so long as the reporting person remains an employee of the issuer (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan).

F2: The option immediately vested with respect to four-thirty-sixths (4/36ths) of the option shares and the remaining option shares will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month on the first day of each month for the next thirty-two months, starting on September 1, 2021, for so long as the reporting person remains an employee of the issuer (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan).

F3: The option shares will vest and become exercisable in equal monthly installments over the 36-month period beginning on the grant date (1/36th will vest on the first day of each month during said 36-month period, with the first vesting date being March 1, 2022) for so long as the reporting person remains an employee of the issuer (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan).